Factual, unbiased, and essential
pandemic news from trusted sources around the globe.
Some good news is on the horizon regarding a vaccine for COVID-19 has come from pharmaceutical company "Moderna," which is one of the companies working to produce a safe and effective vaccine as soon as possible.
As an article on CNBC reports,
"All 45 patients produced neutralizing antibodies, which scientists believe is important for building immunity and provided more promising data that the vaccine may give some protection against the coronavirus. In the trial, each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. Participants received two doses of the potential vaccine.
After two vaccinations, the vaccine elicited a “robust” immune response in all participants in all dose cohorts, Moderna said. The company said the levels of neutralizing antibodies in patients in the high dose group were fourfold higher than in recovered Covid-19 patients."
Fox News interviewed FDA Commissioner Stephen Hahn and here is an excerpt from his comments:
"The FDA, of course, is responsible for calling the balls on the strikes on the safety and effectiveness of the vaccine," Hahn told host Bill Hemmer, "and we have a number of vaccine developers ... who are in the process of developing vaccines for COVID-19, so that does give me encouragement."
Hahn called the Moderna development "good news" and noted that other manufacturers are already past their preliminary phases of vaccine development as well.
"One thing I can tell the American people is that the FDA is on the job working with the vaccine developers, and we want to make sure that the data shows us whether the vaccine is safe and effective so that we can make the right decision for the American people," he said."
According to the reports, if this vaccine works well, the company plans to have dosages manufactured and ready to distribute by possibly the end of 2020 or the beginning of 2021.
Click here to read the article in CNBC.
And click here to read the article in Fox News.